Avidity Biosciences (RNA)

• Market cap: $10.8B
• 1 day: 0.01%
• 5 days: 0.95%
• 1 month: 2.23%
• 3 months: 52.09%
• 6 months: 135.78%
• Year to date: 129.51%
• 1 year: 63.38%
• 5 years: 132.87%
• 10 years: 151.09%
• Sector: Healthcare
• Industry: Biotechnology

About: Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.

Employees: 391